This is a StreetInsider.com Premium Only Page

Neuralstem (CUR) – StreetInsider.com Reports

Sep 2, 2020 08:08 AM Seneca Biopharma (SNCA) Executive Chairman Issues Letter

Oct 28, 2019 09:09 AM Neuralstem (CUR) Becomes Seneca Biopharma (SNCA)

Sep 24, 2019 07:31 AM Neuralstem (CUR) Reports Last Subject Enrollment in Ph. 2 Clinical Trial Evaluating Human Neural Stem Cells in Chronic Stroke Patients

Aug 7, 2019 07:38 AM Neuralstem (CUR) Announces Nasdaq Hearings Panel Grants Request For Continued Listing

Jul 26, 2019 05:44 AM Neuralstem (CUR) Prices 2.77M Share Offering at $2.70/Sh

Jul 16, 2019 07:31 AM Neuralstem (CUR) Plans 1-for-20 Reverse Stock Split

Jul 1, 2019 04:32 PM Neuralstem (CUR) Reports Publication of Results from Phase 1 Clinical Trial Evaluating NSI-566

May 16, 2019 07:08 AM Neuralstem (CUR) Announces Issuance of New Patent Covering Broad Therapeutic Use of Neural Stem Cells

Dec 18, 2018 07:04 AM Neuralstem (CUR) Announces Ken Carter, Ph.D. as Executive Board Chairman

Oct 26, 2018 09:00 AM Neuralstem (CUR) Announces $2.1 Million Registered Direct Offering of Common Stock, Warrants

Aug 6, 2018 07:08 AM Neuralstem (CUR) Announces Jim Scully as Interim CEO

Aug 1, 2018 06:25 AM Neuralstem (CUR) Commences Phase 2 Clinical Trial of NSI-189 in Ischemic Stroke

Jul 23, 2018 11:51 AM Neuralstem (CUR) Announces Presentation of Preclinical Data Demonstrating Neurogenic Compound NSI-189 Improves Cognition and Anxiety in Mouse Model of AD

Apr 10, 2018 07:03 AM Neuralstem (CUR) Reports 1st Surgery Completed in Cervical Cohort of Phase 1 Clinical Trial

Mar 13, 2018 07:10 AM Neuralstem (CUR) Reports Publication of Study in Nature Medicine Showing Benefits of NSI-566 in Primate Model of Spinal Cord Injury

Dec 20, 2017 07:32 AM Neuralstem (CUR) Appoints Xi Chen PhD to Board

Dec 5, 2017 10:11 AM Neuralstem (CUR) Climbs 65%

Dec 5, 2017 07:09 AM Neuralstem (CUR) Announces Positive Updated Data from Phase 2 Study of NSI-189 in Major Depressive Disorder

Nov 16, 2017 04:14 PM Neuralstem (CUR) Reports Presentation of Clinical Data for NSI-189 in Major Depressive Disorder at at ACNP Meeting

Nov 8, 2017 07:39 AM Neuralstem (CUR) Names Dr. David Recker as Chief Medical Officer

Sep 25, 2017 04:12 PM Neuralstem (CUR) Appoints Zhang Zhuo & Cristina Csimma to Board

Sep 21, 2017 09:38 AM Neuralstem (CUR) Climbs on Market Open, Shares up 25%

Sep 7, 2017 07:14 AM Neuralstem (CUR) Reports Issuance of Two U.S. Patents

Jul 27, 2017 09:26 AM Pre-Open Stock Movers 07/27: (CAPR) (SHOR) (FB) Higher; (CUR) (AZN) (CYH) Lower (more...)

Jul 27, 2017 08:35 AM Neuralstem (CUR) Prices 2.25M Offering of Common Stock and Warrants

Jul 26, 2017 06:15 PM After-Hours Movers 07/26: (AXTI) (NTGR) (FB) Higher; (CUR) (CYH) (BWLD) Lower (more...)

Jul 26, 2017 04:54 PM Neuralstem (CUR) Commences Public Offering of Common Stock and Warrants

Jul 25, 2017 09:44 AM Stocks with increasing unusual option volume: CUR COT USG CRC ZYNE

Jul 25, 2017 08:19 AM Neuralstem (CUR) to Resume Trading at 8:45 AM ET

Jul 25, 2017 08:16 AM Neuralstem (CUR) Announces Phase 2 Study of NSI-189 for Major Depressive Disorder Didn't Meet Primary Endpoint

Jul 25, 2017 08:12 AM Neuralstem (CUR) Halted, News Pending

May 17, 2017 04:20 PM Neuralstem (CUR) Completes Dosing in Phase 2 Trial of NSI-189 for Major Depressive Disorder

Apr 12, 2017 07:36 AM Neuralstem (CUR) Adds Four Cohorts to Ongoing Phase 1 Safety Trial of NSI-566 Neural Stem Cells in Spinal Injury

Mar 9, 2017 07:21 AM Neuralstem (CUR) Reports Publication of NSI-566 Data in a Rodent Model of Traumatic Brain Injury

Feb 28, 2017 07:04 AM Neuralstem (CUR) Announces Publication of NSI-189 Preclinical Data

Feb 22, 2017 07:12 AM Neuralstem (CUR) Confirms U.S. Patent Covering NSI-189

Feb 21, 2017 11:45 AM Neuralstem (CUR) Active on Talk of New MDD Patent

Feb 16, 2017 09:40 AM UPDATE: Neuralstem (CUR) Halted on LUDP After Announcing Phase 2 NSI-189 Data Now Expected Ahead of Schedule

Jan 10, 2017 01:34 PM Neuralstem (CUR) Resumes Trading; Shares up 25%

Jan 10, 2017 01:30 PM Neuralstem (CUR) halted LUDP, last up 16.5%

Jan 6, 2017 01:02 PM Neuralstem (CUR) Announces a 1-for-13 Reverse Stock Split

Nov 8, 2016 03:24 PM Roth Capital Affirms Neuralstem (CUR) at 'Buy'; Says Rest of 2016 Will be Uneventful

Nov 8, 2016 07:37 AM Neuralstem (CUR) Misses Q3 EPS by 2c

Oct 20, 2016 08:00 AM Neuralstem (CUR) Announces Presentation of NSI-189 Preclinical Data at RRS Annual Meeting

Oct 4, 2016 10:16 AM Notable Analyst Rating Changes 10/4: (KBR) (RIG) (CBS) Upgraded; (WFC) (DEPO) (KMI) Downgraded

Oct 4, 2016 10:14 AM UPDATE: Brean Capital Assumes Neuralstem (CUR) at Buy

Sep 21, 2016 12:13 PM Streetinsider.com's Hot Lunchtime Reads 9/21: (LL) (RHT) (CUR) (TSLA)

Sep 21, 2016 11:56 AM Roth Capital Affirms Neuralstem (CUR) at 'Buy' Amid NSI-189 Enrollment Milestone

Sep 21, 2016 08:35 AM Neuralstem (CUR) Surpasses 50% Enrollment Mark in Phase 2 MDD Study

Sep 12, 2016 09:23 AM Pre-Open Stock Movers 09/12: (RPTP) (CLSN) (PRGO) Higher; (GERN) (AMRN) (PII) Lower (more...)